Human CEACAM-6/CD66c Antibody Summary
Lys35-Gly320
Accession # P40199
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
Detection of CEACAM‑6/CD66c in Human Granulocytes by Flow Cytometry. Human whole blood granulocytes were stained with Mouse Anti-Human CEACAM-6/CD66c Monoclonal Antibody (Catalog # MAB3934, filled histogram) or isotype control antibody (Catalog # MAB003, open histogram), followed by Phycoerythrin-conjugated Anti-Mouse IgG F(ab')2Secondary Antibody (Catalog # F0102B).
Detection of CEACAM‑6/CD66c in HEK293 Human Cell Line Transfected with Human CEACAM-6/CD66c and eGFP by Flow Cytometry. HEK293 human embryonic kidney cell line transfected with (A) human CEACAM-6/CD66c or (B) irrelevant transfectants and eGFP was stained with Mouse Anti-Human CEACAM-6/CD66c Monoclonal Antibody (Catalog # MAB3934) followed by Allophycocyanin-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # F0101B). Quadrant markers were set based on control antibody staining (Catalog # MAB003).
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: CEACAM-6/CD66c
Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM-6), previously called nonspecific cross‑reacting antigen (NCA) or CD66c, is one of seven human CEACAM family members within the immunoglobulin superfamily (1-4). In humans, CEACAMs include type I transmembrane proteins (CEACAM-1, -3, and -4) and Glycosylphosphatidylinositol (GPI)-linked molecules (CEACAM-5 through -8) (1). There is no human CEACAM-2. Human CEACAM-6 is a 90 kDa, GPI-linked membrane protein that contains a 34 amino acid (aa) signal sequence, a 286 aa extracellular domain (ECD), and a 24 aa hydrophobic C-terminal propeptide. The GPI membrane anchor is attached at the C-terminus following cleavage of the propeptide. CEACAM-6 contains one N-terminal V-type Ig-like domain (N domain), followed by two C2-type Ig-like domains (2-4). It shows considerable glycosylation, including (sialyl) LewisX, which mediates binding to E-Selectin, Galectins and some bacterial fimbrae (1, 2). Mature human CEACAM-6 shows 84%, 85%, 80%, 87% and 51% aa identity to the equivalent extracellular regions of human CEACAMs -1, -5 (CEA) and -8, rhesus CEACAM-2, and bovine CEACAM-6, respectively. CEACAM-6 is expressed by granulocytes and their precursors. Activation enhances surface expression by mobilizing CEACAM-6 from storage in azurophilic granules (5, 6). It often shows aberrant expression in acute lymphocytic leukemias (10). CEACAM-6 is also expressed in epithelia of various organs and is upregulated in pancreatic and colon adenocarcinomas and hyperplastic polyps (7, 8). Over-expression confers resistance to adhesion-related apoptosis (anoikis) in tumor cells (8, 9). CEACAM-6 is an intercellular adhesion molecule, forming both homotypic, and heterotypic bonds with CEACAM-1, -5 and -8 through interaction of the V-type Ig-like domains (11, 12). Cross-linking of neutrophil CEACAM-6 augments Integrin alpha v beta 3 and beta 2-mediated adhesion, apparently by Src and Caveolin-mediated inside-out Integrin activation (8, 13, 14).
- Beauchemin, N. et al. (1999) Exp. Cell Res. 252:243.
- Skubitz, K.M. et al. (1999) J. Biol. Regul. Homeost. Agents 13:244.
- Barnett, T. et al. (1988) Genomics 3:59.
- Tawaragi, Y. et al. (1988) Biochem. Biophys. Res. Comm. 150:89.
- Kuroki, M. et al. (1995) Immunol. Invest. 24:829.
- Ducker, T.P. and K.M. Skubitz (1992) J. Leukoc. Biol. 52:11.
- Scholzel, S. et al. (2000) Am. J. Pathol. 156:595.
- Duxbury, M.S. et al. (2004) J. Biol. Chem. 279:23176.
- Ilantzis, C. et al. (2002) Neoplasia 4:151.
- Kalina, T. et al. (2005) BMC Cancer 5:38.
- Oikawa, S. et al. (1992) Biochem. Biophys. Res. Commun. 186:881.
- Kuroki, M. et al. (2001) J. Leukoc. Biol. 70:543.
- Duxbury, M.S. et al. (2004) Biochem. Biophys. Res. Comm. 317:133.
- Skubitz, K.M. et al. (1999) J. Leukoc. Biol. 60:106.
Product Datasheets
Citations for Human CEACAM-6/CD66c Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
2
Citations: Showing 1 - 2
Filter your results:
Filter by:
-
CEACAM 1, 3, 5 and 6 -positive classical monocytes correlate with interstitial lung disease in early systemic sclerosis
Authors: Kana Yokoyama, Hiroki Mitoma, Shotaro Kawano, Yusuke Yamauchi, Qiaolei Wang, Masahiro Ayano et al.
Frontiers in Immunology
-
Regulation of CEACAM Family Members by IBD-Associated Triggers in Intestinal Epithelial Cells, Their Correlation to Inflammation and Relevance to IBD Pathogenesis
Authors: Gonzalo Saiz-Gonzalo, Naomi Hanrahan, Valerio Rossini, Raminder Singh, Mary Ahern, Maebh Kelleher et al.
Frontiers in Immunology
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human CEACAM-6/CD66c Antibody
Average Rating: 3 (Based on 1 Review)
Have you used Human CEACAM-6/CD66c Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Filter by: